Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0014
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with A, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Abacavir, Acetylcysteine (N-acetylcysteine), Aciclovir = Acyclovir (USAN), Adenosine, Adrenaline = Epinephrine (rINN), Albendazole, Alginate compounds (Gaviscon®), Alimemazine (trimeprazine— former BAN and USAN), Alteplase (tissue-type plasminogen activator [rt-PA]), Amikacin, Amiodarone, Amlodipine, Amodiaquine with artesunate, Amoxicillin = Amoxycillin (former BAN), Amphotericin B, Ampicillin, Anti-vascular endothelial growth factors (for ROP), Arginine (L-arginine), Artemether with lumefantrine, Aspirin = acetylsalicylic acid (INN), Atosiban, Atracurium, Atropine, and Azithromycin
Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0034
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with V, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Vancomycin, Varicella-zoster immunoglobulin and vaccine, Vasopressin, desmopressin, and terlipressin, Vigabatrin, Vitamin A (retinol), Vitamin B12 (hydroxocobalamin), Vitamin D (special formulations), Vitamin D (standard formulations), Vitamin E (alpha tocopherol), Vitamin K1 = phytomenadione (rINN), phytonadione (USAP), and Vitamins (multi-vitamins)
{"title":"V","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0034","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0034","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with V, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Vancomycin, Varicella-zoster immunoglobulin and vaccine, Vasopressin, desmopressin, and terlipressin, Vigabatrin, Vitamin A (retinol), Vitamin B12 (hydroxocobalamin), Vitamin D (special formulations), Vitamin D (standard formulations), Vitamin E (alpha tocopherol), Vitamin K1 = phytomenadione (rINN), phytonadione (USAP), and Vitamins (multi-vitamins)","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78789818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0024
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with L, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Labetalol hydrochloride, Lactoferrin, Lamivudine, Lamotrigine, Lansoprazole, Levetiracetam, Levosimendan, Levothyroxine sodium, Lidocaine = Lignocaine (former BAN), Linezolid, Lipid emulsions for parenteral nutrition, Loperamide, Lopinavir with ritonavir, Lorazepam, and Low-molecular-weight heparins and other anticoagulants
{"title":"L","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0024","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0024","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with L, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Labetalol hydrochloride, Lactoferrin, Lamivudine, Lamotrigine, Lansoprazole, Levetiracetam, Levosimendan, Levothyroxine sodium, Lidocaine = Lignocaine (former BAN), Linezolid, Lipid emulsions for parenteral nutrition, Loperamide, Lopinavir with ritonavir, Lorazepam, and Low-molecular-weight heparins and other anticoagulants","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82866466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0015
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with B, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of BCG (Bacillus Calmette– Guérin) vaccine, Betaine, Betamethasone, Biotin, Blood, Bosentan, Breast milk fortifiers, Budesonide, and Bupivacaine
{"title":"B","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0015","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0015","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with B, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of BCG (Bacillus Calmette– Guérin) vaccine, Betaine, Betamethasone, Biotin, Blood, Bosentan, Breast milk fortifiers, Budesonide, and Bupivacaine","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87417763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0018
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with E, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Enemas, laxatives, and suppositories, Enoxaparin, Enzyme replacement therapy, Epoetin (recombinant human erythropoietin = rEPO), Epoprostenol and other prostanoids (iloprost and teoprostinil), Erythromycin, Esomeprazole, Ethambutol, and Eye drops (and ointments)
{"title":"E","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0018","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0018","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with E, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Enemas, laxatives, and suppositories, Enoxaparin, Enzyme replacement therapy, Epoetin (recombinant human erythropoietin = rEPO), Epoprostenol and other prostanoids (iloprost and teoprostinil), Erythromycin, Esomeprazole, Ethambutol, and Eye drops (and ointments)","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"78 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80266867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0031
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with S, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Salbutamol = Albuterol (USAN), Sildenafil, Skin care and skin sterility, Sodium phenylbutyrate and glycerol phenylbutyrate, Sodium benzoate, Sodium bicarbonate, Sodium chloride, Sodium fusidate (fusidic acid), Sodium valproate, Sotalol, Spiramycin, Spironolactone, Stiripentol, Streptokinase, Sucrose, Sulfadiazine = Sulphadiazine (former BAN), Surfactants, and Suxamethonium = Succinylcholine (USAN)
Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0032
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with T, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Teicoplanin, Tenofovir, Tetracaine = Amethocaine (former BAN), Tetracosactide = Tetracosactrin (former BAN), Tetracycline, Thiopental sodium = Thiopentone sodium (former BAN), Tobramycin, Topiramate, Tramadol, Tranexamic acid, Trimethoprim, and Trometamol = Tromethamine (USAN)
Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0025
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with M, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Magnesium sulfate (Magnesium sulphate = former BAN), Mebendazole, Mefloquine, Melatonin, Meningococcal vaccines, Mercaptamine (Cysteamine— former BAN), Meropenem, Methadone, Methyldopa, Methylthioninium chloride (Methylene blue = former BAN), Metoclopramide, Metronidazole, Micafungin, Miconazole, Midazolam, Formula milk thickeners and anti-reflux milks, Milrinone, Misoprostol, Mivacurium, Morphine, and Mupirocin
{"title":"M","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0025","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0025","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with M, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Magnesium sulfate (Magnesium sulphate = former BAN), Mebendazole, Mefloquine, Melatonin, Meningococcal vaccines, Mercaptamine (Cysteamine— former BAN), Meropenem, Methadone, Methyldopa, Methylthioninium chloride (Methylene blue = former BAN), Metoclopramide, Metronidazole, Micafungin, Miconazole, Midazolam, Formula milk thickeners and anti-reflux milks, Milrinone, Misoprostol, Mivacurium, Morphine, and Mupirocin","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73678912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0030
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with R, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Radiological contrast media, Raltegravir, Ranitidine, Recombinant human granulocyte colony-stimulating factors (rhG-CSF), Remifentanil, Rhesus (D) immunoglobulin, Ribavirin = Tribavirin (former BAN), Rifampicin = Rifampin (USAN), Rocuronium, Rotavirus vaccines, and Rubella vaccine
Pub Date : 2020-03-01DOI: 10.1093/med/9780198840787.003.0026
Sean Ainsworth
This chapter presents information on neonatal drugs that begin with N, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Naloxone, Neostigmine (and pyridostigmine), Nevirapine, Nifedipine, Nitazoxanide, Nitisinone, Nitric oxide, Nitrofurantoin, Nitrous oxide, Noradrenaline = Norepinephrine (rINN), and Nystatin
{"title":"N","authors":"Sean Ainsworth","doi":"10.1093/med/9780198840787.003.0026","DOIUrl":"https://doi.org/10.1093/med/9780198840787.003.0026","url":null,"abstract":"This chapter presents information on neonatal drugs that begin with N, including use, pharmacology, adverse effects, fetal and infant implications of maternal treatment, treatment, and supply of Naloxone, Neostigmine (and pyridostigmine), Nevirapine, Nifedipine, Nitazoxanide, Nitisinone, Nitric oxide, Nitrofurantoin, Nitrous oxide, Noradrenaline = Norepinephrine (rINN), and Nystatin","PeriodicalId":18908,"journal":{"name":"Neonatal Formulary","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83165875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：